bioMD to pay $650k for half of Celxcel

Biomedical device company bioMD has reached an agreement to acquire a 50 per cent stake in Celxcel, an Australian private unlisted company formed in 2001 to commercialise the use of kangaroo tissue as a suitable biological tissue implant (bioimplant) for